BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12897601)

  • 1. It is money that matters: decision analysis and cost-effectiveness analysis.
    Kocher MS; Henley MB
    Clin Orthop Relat Res; 2003 Aug; (413):106-16. PubMed ID: 12897601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the essentials of economic evaluation.
    Schmid GP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 4():S6-13. PubMed ID: 7493197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM
    Ophthalmic Epidemiol; 2008; 15(2):76-83. PubMed ID: 18432490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the medical decision].
    Colin C; Delahaye F; Ecochard R; Landrivon G; Rabilloud M; Teboul F; Matillon Y
    Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1597-603. PubMed ID: 8010859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision analysis in nuclear medicine.
    Gambhir SS
    J Nucl Med; 1999 Sep; 40(9):1570-81. PubMed ID: 10492381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Decision analysis in antibiotic therapy].
    Calvo MV; Domínguez-Gil A
    Enferm Infecc Microbiol Clin; 1990 Apr; 8(4):199-207. PubMed ID: 2128607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primer: using decision analysis to improve clinical decision making in urology.
    Elkin EB; Vickers AJ; Kattan MW
    Nat Clin Pract Urol; 2006 Aug; 3(8):439-48. PubMed ID: 16902520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
    Elbasha EH
    Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis for clinical procedures in oncology.
    Weinstein MC
    Bull Cancer; 1980; 67(5):491-500. PubMed ID: 6783150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of information on preference heterogeneity and individualized care.
    Basu A; Meltzer D
    Med Decis Making; 2007; 27(2):112-27. PubMed ID: 17409362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A primer on use of decision analysis methodology in hand surgery.
    Chen NC; Shauver MJ; Chung KC
    J Hand Surg Am; 2009; 34(6):983-90. PubMed ID: 19481363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decisions in case of "problematic" cost-effectiveness ratios based on the example of a clinical trial in rehabilitation care].
    Leidl R; Jacobi E; Knab J; Schweikert B
    Gesundheitswesen; 2006 Apr; 68(4):249-56. PubMed ID: 16705561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods.
    Groot Koerkamp B; Myriam Hunink MG; Stijnen T; Weinstein MC
    Health Econ; 2006 Apr; 15(4):383-92. PubMed ID: 16389669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
    Fletcher EC; Lade RJ; Adewoyin T; Chong NV
    Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness considerations in critical care.
    Rubenfeld GD
    New Horiz; 1998 Feb; 6(1):33-40. PubMed ID: 9508256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.